annual CFO:
-$112.16M+$134.90M(+54.60%)Summary
- As of today (May 24, 2025), ARQT annual cash flow from operations is -$112.16 million, with the most recent change of +$134.90 million (+54.60%) on December 31, 2024.
- During the last 3 years, ARQT annual CFO has risen by +$62.47 million (+35.77%).
- ARQT annual CFO is now -2871.07% below its all-time high of -$3.77 million, reached on December 31, 2017.
Performance
ARQT Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$30.38M-$29.63M(-3961.50%)Summary
- As of today (May 24, 2025), ARQT quarterly cash flow from operations is -$30.38 million, with the most recent change of -$29.63 million (-3961.50%) on March 31, 2025.
- Over the past year, ARQT quarterly CFO has increased by +$1.22 million (+3.87%).
- ARQT quarterly CFO is now -3961.50% below its all-time high of -$748.00 thousand, reached on December 31, 2024.
Performance
ARQT quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$110.94M+$1.22M(+1.09%)Summary
- As of today (May 24, 2025), ARQT TTM cash flow from operations is -$110.94 million, with the most recent change of +$1.22 million (+1.09%) on March 31, 2025.
- Over the past year, ARQT TTM CFO has increased by +$87.38 million (+44.06%).
- ARQT TTM CFO is now -1468.21% below its all-time high of -$7.07 million, reached on March 31, 2019.
Performance
ARQT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ARQT Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +54.6% | +3.9% | +44.1% |
3 y3 years | +35.8% | +46.7% | +40.2% |
5 y5 years | -161.8% | -44.6% | -95.4% |
ARQT Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +56.5% | -3961.5% | +62.2% | at high | +61.2% |
5 y | 5-year | -161.8% | +56.5% | -3961.5% | +62.2% | -95.4% | +61.2% |
alltime | all time | -2871.1% | +56.5% | -3961.5% | +62.2% | -1468.2% | +61.2% |
ARQT Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$30.38M(+3961.5%) | -$110.94M(-1.1%) |
Dec 2024 | -$112.16M(-54.6%) | -$748.00K(-97.8%) | -$112.16M(-33.1%) |
Sep 2024 | - | -$34.69M(-23.1%) | -$167.65M(-5.3%) |
Jun 2024 | - | -$45.12M(+42.8%) | -$176.95M(-10.8%) |
Mar 2024 | - | -$31.60M(-43.8%) | -$198.32M(-19.7%) |
Dec 2023 | -$247.06M(-4.1%) | -$56.24M(+27.9%) | -$247.06M(-5.7%) |
Sep 2023 | - | -$43.98M(-33.8%) | -$261.88M(-8.3%) |
Jun 2023 | - | -$66.48M(-17.2%) | -$285.59M(+1.6%) |
Mar 2023 | - | -$80.34M(+13.1%) | -$281.08M(+9.1%) |
Dec 2022 | -$257.71M(+47.6%) | -$71.06M(+5.0%) | -$257.71M(+8.1%) |
Sep 2022 | - | -$67.69M(+9.2%) | -$238.36M(+12.7%) |
Jun 2022 | - | -$61.98M(+8.8%) | -$211.55M(+14.1%) |
Mar 2022 | - | -$56.98M(+10.2%) | -$185.40M(+6.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$174.63M(+54.5%) | -$51.71M(+26.5%) | -$174.63M(+12.3%) |
Sep 2021 | - | -$40.88M(+14.1%) | -$155.49M(+4.9%) |
Jun 2021 | - | -$35.83M(-22.4%) | -$148.30M(+7.3%) |
Mar 2021 | - | -$46.20M(+41.9%) | -$138.23M(+22.3%) |
Dec 2020 | -$113.03M(+163.9%) | -$32.57M(-3.3%) | -$113.03M(+16.2%) |
Sep 2020 | - | -$33.69M(+30.8%) | -$97.26M(+30.9%) |
Jun 2020 | - | -$25.76M(+22.6%) | -$74.29M(+30.9%) |
Mar 2020 | - | -$21.01M(+25.1%) | -$56.77M(+32.5%) |
Dec 2019 | -$42.84M(+204.1%) | -$16.80M(+56.7%) | -$42.84M(+64.5%) |
Sep 2019 | - | -$10.72M(+30.1%) | -$26.04M(+70.0%) |
Jun 2019 | - | -$8.24M(+16.5%) | -$15.32M(+116.5%) |
Mar 2019 | - | -$7.07M | -$7.07M |
Dec 2018 | -$14.09M(+273.1%) | - | - |
Dec 2017 | -$3.77M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual cash flow from operations?
- What is the all time high annual CFO for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual CFO year-on-year change?
- What is Arcutis Biotherapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly CFO year-on-year change?
- What is Arcutis Biotherapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM CFO year-on-year change?
What is Arcutis Biotherapeutics annual cash flow from operations?
The current annual CFO of ARQT is -$112.16M
What is the all time high annual CFO for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual cash flow from operations is -$3.77M
What is Arcutis Biotherapeutics annual CFO year-on-year change?
Over the past year, ARQT annual cash flow from operations has changed by +$134.90M (+54.60%)
What is Arcutis Biotherapeutics quarterly cash flow from operations?
The current quarterly CFO of ARQT is -$30.38M
What is the all time high quarterly CFO for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly cash flow from operations is -$748.00K
What is Arcutis Biotherapeutics quarterly CFO year-on-year change?
Over the past year, ARQT quarterly cash flow from operations has changed by +$1.22M (+3.87%)
What is Arcutis Biotherapeutics TTM cash flow from operations?
The current TTM CFO of ARQT is -$110.94M
What is the all time high TTM CFO for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM cash flow from operations is -$7.07M
What is Arcutis Biotherapeutics TTM CFO year-on-year change?
Over the past year, ARQT TTM cash flow from operations has changed by +$87.38M (+44.06%)